T 0643/12 (Lenvatinib mesylate polymorphs/EISAI) of 18.06.2014

European Case Law Identifier: ECLI:EP:BA:2014:T064312.20140618
Date of decision: 18 June 2014
Case number: T 0643/12
Petition for review of: -
Application number: 04807580.8
IPC class: A61K 31/47 A61P 9/10 A61P 43/00 C07D 215/48 A61P 17/06 A61P 35/00 A61P 29/00 A61P 27/02
Language of proceedings: English
Distribution: No distribution (D)
Download: Decision in English
OJ versions: No OJ links found
Other decisions for this case: -
Abstracts for this decision: -
Application title: CRYSTAL OF SALT OF 4-(3-CHLORO-4-(CYCLOPROPYLAMINOCARBONYL)AMINO-PHENOXY)-7-METHOXY-6-QUINOLINECARBOXAMIDE OR OF SOLVATE THEREOF AND PROCESSES FOR PRODUCING THESE
Applicant name: Eisai R&D Management Co., Ltd.
Opponent name: -
Board: 3.3.01
Headnote: -
Relevant legal provisions: European Patent Convention Art 123(2)European Patent Convention Art 54 European Patent Convention Art 56 European Patent Convention Art 84 European Patent Convention R 43(6)
Keywords: Main request: inventive step (yes) - unexpected balance of properties
Catchword: -
Cited cases: T 0777/08
Citing cases: T 1450/14 T 2730/16

Order

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The case is remitted to the department of first instance with the order to grant a patent on the basis of claims 1 to 13 of the main request as filed with letter of 16 June 2014 and a description to be adapted thereto.